paclitaxel has been researched along with B16 Melanoma in 131 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (14.50) | 18.2507 |
| 2000's | 33 (25.19) | 29.6817 |
| 2010's | 72 (54.96) | 24.3611 |
| 2020's | 7 (5.34) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, CT; Cheruvallath, ZS; Georg, GI; Himes, RH; Mejillano, MR | 1 |
| Ali, SM; Aubé, J; Georg, GI; Hoemann, MZ; Jayasinghe, LR; McCall, R; Mitscher, LA | 1 |
| Boge, TC; Georg, GI; Himes, RH; Vander Velde, DG | 1 |
| Bernacki, RJ; Bissery, MC; Bounaud, PY; Kuduk, SD; Michaud, E; Ojima, I; Pera, P; Slater, JC; Veith, JM; Vrignaud, P | 1 |
| Ali, SM; Aubé, J; Georg, GI; Hoemann, MZ; Jayasinghe, LR; Mitscher, LA | 1 |
| Chidester, CG; DeKoning, TF; Dobrowolski, PJ; Gebhard, I; Johnson, RA; Kelly, RC; Lopes, NM; Mattern, SJ; McGovren, JP; Nidy, EG; Pitts, TW; Qualls, SJ; Weed, SD; Wicnienski, NA | 1 |
| Chiba, J; Ishiyama, T; Iwahana, M; Jimbo, T; Soga, T; Takeda, Y; Tanaka, N; Terasawa, H; Uoto, K; Yoshino, T | 1 |
| Licínio, MA; Machado, KE; Nunes, RJ; Oliveira, KN; Santos-Bubniak, L; Santos-Silva, MC | 1 |
| Choi, BK; Fudou, R; Furukawa, H; Han, C; Imokawa, G; Kaida, K; Ojika, M; Tomura, T | 1 |
| Eguchi, M; Hashimoto, H; Hirata, S; Ishigami, I; Kasai, A; Mizuguchi, H; Ogawara, KI; Ono, R; Sakurai, F; Shuwari, N; Tachibana, M; Tanuma, M | 1 |
| Fu, X; Gu, Z; Huang, Y; Lin, G; Qi, T; Shi, Y; Sun, Q; Wang, Q; Zhai, G; Zhang, Y; Zhao, X | 1 |
| Deng, H; Hu, M; Hu, Q; Kong, L; Tu, K; Wang, Y; Yang, C; Yang, T; Zhang, Z | 1 |
| Gao, S; Hu, Z; Lu, W; Xu, J; Zheng, B | 1 |
| Cao, X; Jin, Y; Liu, Y; Tan, T; Xia, Q; Yu, H; Zhou, H; Zhu, D | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Ju, MS; Lin, CK; Yang, CH | 1 |
| Fukui, M; Katsumi, H; Kimura, H; Nakao, Y; Sakane, T; Shimizu, E; Yamamoto, A; Yamashita, S; Yoshioka, A | 1 |
| Alberti, D; Bitonto, V; Geninatti Crich, S; Rakhshan, S; Stefania, R | 1 |
| Li, C; Li, Z; Luan, Y; Wu, J; Zhang, H; Zhao, D | 1 |
| Lian, Z; Liang, G; Tang, W; Yang, J; Yuan, Y; Zhao, Z | 1 |
| Du, G; Liu, Q; Meng, X; Sun, S; Tian, J; Wang, H; Wang, W; Wu, Z; Ye, L | 1 |
| Chuang, VTG; Fang, J; Ishida, T; Ishima, Y; Kinoshita, R; Maeda, H; Maruyama, T; Nakamura, H; Okuhira, K; Otagiri, M; Shimizu, T; Watanabe, H | 1 |
| Boisgerault, N; Coffey, M; Diaz, RM; Evgin, L; Harrington, K; Ilett, E; Kottke, T; Melcher, A; Pandha, H; Rommelfanger, D; Selby, P; Shim, KG; Thompson, J; Vile, R; Zaidi, S | 1 |
| Gao, X; Hu, X; Li, G; Song, Q; Tan, S; Wu, T; Yin, Y; Zhang, Z; Zhao, Y | 1 |
| Chaurasiya, B; Du, Y; Huang, L; Sun, C; Tu, J; Webster, TJ; Xia, J | 1 |
| Eshita, Y; Ji, RC; Kobayashi, T; Kubota, N; Mizuno, M; Onishi, M; Onishi, Y; Yoshida, J | 3 |
| Ingle, SG; Monpara, JD; Pai, RV; Vavia, PR | 1 |
| Chen, Q; Fang, X; Liang, H; Meng, L; Ren, X; Sha, X; Wang, X; Zhang, X | 1 |
| Ghosh, S; Guo, C; He, H; Korzun, WJ; Wang, J; Wang, XY; Yang, H | 1 |
| Burkert, SC; He, X; Kagan, VE; Kapralov, AA; Shurin, GV; Shurin, MR; Star, A; White, DL | 1 |
| He, Q; Li, M; Mei, L; Rao, J; Tang, X; Wei, J; Xia, C; Yin, S; Zhang, Z | 1 |
| Ding, H; Ge, Y; Li, L; Yang, M; Zhu, Y | 1 |
| Cun, X; He, Q; Li, M; Liu, Y; Tang, X; Wei, J; Xu, C; Yang, Y; Yin, S; Yu, Q; Zhang, Z | 1 |
| Ali, N; Banerjee, I; Bharti, R; Chakrabarti, P; Chattopadhyay, S; De, M; Dey, G; Kundu, SC; Mandal, M; Reis, RL | 1 |
| Makino, K; Takeuchi, I | 1 |
| Bhatt, H; Biswas, S; Ghosh, B; Kiran Rompicharla, SV | 1 |
| Cao, L; Shi, S; Sun, X; Xu, C; Zeng, Q; Zhang, Z | 1 |
| Balakrishnan, B; Banerjee, R; Joshi, N; More, P; Saha, R; Shanmugam, T | 1 |
| Glowala-Kosinska, M; Gogler-Piglowska, A; Toma, A; Vydra, N; Widlak, W | 1 |
| Gutkin, DW; Han, B; Keskinov, AA; Ma, Y; Shurin, GV; Shurin, MR; Zhong, H | 1 |
| Anwar, MF; Asif, M; Beg, MN; Garg, V; Gaur, S; Kardam, H; Suri, S; Yadav, D | 1 |
| Battogtokh, G; Ko, YT | 1 |
| Castioni, N; Elia, G; Neri, D; Pretto, F | 1 |
| Gota, V; Mehta, M; Patel, K; Patil, A; Vavia, P | 1 |
| Ko, YT; Ruttala, HB | 1 |
| Chen, X; Li, M; Lin, J; Liu, H; Lv, S; Song, W; Tang, Z; Zhang, D | 1 |
| Chen, P; Du, LC; Hu, HZ; Li, J; Li, YH; Luo, S; Tang, J; Wang, YS; Wei, YQ; Wen, YJ; Yang, DB; Zhang, P; Zhao, X | 1 |
| Fu, H; He, Q; Hu, GL | 1 |
| Chen, X; Feng, T; Lam, MH; Liang, H; Lin, L; Tian, H; Xie, Z; Xu, C | 1 |
| Fang, J; Joo, KI; Liu, Y; Wang, P; Wong, MK | 1 |
| Banerjee, R; Joshi, KS; Joshi, N; Shirsath, N; Singh, A | 1 |
| Chen, W; Chen, Y; Dong, M; Fu, H; He, Q; Hu, G; Kuang, Q; Lu, L; Shi, K; Yang, Y; Zhang, L | 1 |
| Araki, T; Higaki, K; Kawai, R; Ogawara, K; Ono, T; Suzuki, H; Watanabe, T | 1 |
| Feng, L; Li, M; Liu, F; Liu, Y; Zhang, L; Zhang, N | 1 |
| Chen, Y; Fu, Y; He, T; Jia, L; Li, L; Liu, G; Lu, XA; Luo, Y; Qi, F | 1 |
| Barile, E; De, SK; Fisher, PB; Oshima, RG; Pellecchia, M; Purves, A; Quinn, BA; Stebbins, JL; Wang, S; Wu, B; Zharkikh, I | 1 |
| Cao, Z; Gao, H; He, Q; Li, J; Liu, Y; Long, Y; Qian, J; Qiu, Y; Shi, K; Wang, Y; Yang, B; Yang, P; Zhang, Q; Zhang, Z | 1 |
| Heo, MB; Kim, SY; Lim, YT; Yun, WS | 1 |
| El Kourati, F; Kesharwani, SS; Kumar, S; Muley, P; Tummala, H | 1 |
| Alexander, C; Bosquillon, C; Frédérick, R; Luo, T; Magnusson, J; Préat, V; Vanbever, R | 1 |
| Aiba, N; Itoh, G; Iwabuchi, Y; Kohyama, A; Kuriyama, S; Shibata, H; Tanaka, M; Yashiro, M | 1 |
| Contente, TC; Guido, MC; Kretzer, IF; Maranhão, RC; Maria, DA | 1 |
| Bhadra, MP; Bhadra, U; Garikapati, KR; Reddy, BV; Reddy, SG; Reddy, TL; Yadav, JS | 1 |
| Khanna, V; Kim, H; Kirtane, AR; Koniar, B; Panyam, J; Sadhukha, T | 1 |
| Berghaus, A; Dellian, M; Eichhorn, ME; Michaelis, U; Sauer, B; Strieth, S; Teifel, M; Werner, A | 1 |
| Benezra, R; Bertolini, F; Colleoni, M; Daenen, LG; Emmenegger, U; Henke, E; Kerbel, RS; Langenberg, MH; Man, S; Mancuso, P; Roodhart, JM; Shaked, Y; Strieter, RM; Tang, T; Voest, EE; Witte, L; Xu, P; Zhu, Z | 1 |
| Castro, GA; Maria, DA; Rodrigues, CJ; Sgarbieri, VC | 1 |
| Gude, RP; Murthy, RS; Shenoy, VS | 1 |
| Kumar, S; Lavhale, MS; Mishra, SH; Sitasawad, SL | 1 |
| Feng, Z; Gough, D; Howell, SB; Yu, L; Zhao, G | 1 |
| Bartheldyová, E; Korvasová, Z; Koudelka, S; Masek, J; Plocková, J; Skrabalová, M; Turánek, J; Turánek-Knötigová, P | 1 |
| Cai, L; Chen, L; Chen, X; Fu, A; Hu, J; Li, X; Liu, Y; Mao, Y; Shao, X; Wang, X; Wang, Y; Wei, Y; Wu, W; Xiao, W; Yang, L; Ye, X | 1 |
| Moon, EY; Oh, JM | 1 |
| Beninati, S; Lentini, A; Mattioli, P; Provenzano, B; Tabolacci, C | 1 |
| Bhaskar, S; Roy, A; Singh, MS; Upadhyay, P | 1 |
| Cai, L; Chen, L; Chen, X; Deng, L; Pei, H; Wang, X; Wei, Y; Zhao, X | 1 |
| Åhgren, A; Hasumi, Y; Heldin, CH; Hellberg, C; Kłosowska-Wardęga, A | 1 |
| Hao, YL; Huang, ZQ; Liu, N; Nie, SH; Sun, MM; Tai, W; Zhang, XN | 1 |
| Li, J; Liu, C; Liu, F; Liu, J; Qu, X; Wang, Q; Yang, Z; Zhang, C; Zhao, L; Zhu, L | 1 |
| Chen, Y; Fang, X; Hao, J; Sha, X; Shi, Y; Zhang, W | 1 |
| Bani, MR; Bassi, A; Berndt, A; Galler, K; Giavazzi, R; Kaspar, M; Kosmehl, H; Micotti, E; Moschetta, M; Neri, D; Oliva, P; Pretto, F; Richter, P; Schwager, K; Trachsel, E; Valbusa, G | 1 |
| Beck-Broichsitter, M; Bege, N; Curdy, C; Endres, T; Kissel, T; Librizzi, D; Merkel, O; Petersen, H; Renette, T | 1 |
| Feng, LX; Li, M; Li, YX; Yang, XY; Zhang, L; Zhang, N | 1 |
| Leppla, SH; Liu, S; McKenzie, AT; Wein, AN; Zhang, Y | 1 |
| Cai, L; Chen, L; Chen, X; Duan, X; Li, X; Qian, Z; Qiu, N; Wang, W; Wang, X; Wei, Y; Wen, J; Yang, L | 1 |
| Kretzer, IF; Maranhão, RC; Maria, DA | 1 |
| Wang, T; Yao, J; Zhang, L; Zhang, Q; Zhou, J | 1 |
| Liu, H; Yao, J; Zhang, L; Zhang, Q; Zhou, J | 1 |
| Nie, G; Wang, H; Wu, Y; Zhao, R | 1 |
| Dubowchik, GM; Kerr, DE; Senter, PD; Siemers, NO; Vrudhula, VM | 1 |
| Kunstfeld, R; Michaelis, U; Naujoks, K; Petzelbauer, P; Teifel, M; Umek, W; Wickenhauser, G; Wolff, K | 1 |
| Baker, B; Bolton, M; De Vries, P; Garzone, P; Kumar, A; Shaffer, S; Singer, JW; Vawter, E | 1 |
| Cao, Y; Han, R; Liu, HY; Wang, F; Xu, SF | 1 |
| Amano, Y; Chiba, K; Egi, Y; Fujii, A; Goto, N; Hayashi, K; Kataoka, H; Katayama, K; Kondo, T; Nakajima, M; Ohtsuki, M; Oshita, K; Uehata, M | 1 |
| Entin, I; Keisari, Y; Korenstein, R; Plotnikov, A | 1 |
| Cao, Y; Fu, Z; Han, R; Liu, H; Wang, F; Zhao, W | 1 |
| Albeck, M; Cohen, YI; Freidkin, I; Kalechman, Y; Kershenovich, A; Khomenok, G; Lebenthal, I; Longo, DL; Mardor, Y; Michowiz, S; Orenstein, A; Ram, Z; Rappaport, ZH; Sredni, B; Teitz, S; Weil, M | 1 |
| Dellian, M; Eichhorn, ME; Michaelis, U; Sauer, B; Schulze, B; Strieth, S; Teifel, M | 1 |
| Kim, YS; Kwak, YS; Park, JD; Shin, HJ; Song, YB | 1 |
| Gu, W; Huang, J; Li, Y; Sui, H; Xu, Z; Yan, Z; Yang, Y; Zhou, Z | 1 |
| Chung, H; Jeong, SY; Kwon, IC; Lee, IH; Park, YT; Roh, K | 1 |
| Couto, RD; Fernandes, DC; Ibañez, OC; Maranhão, RC; Maria, DA; Rodrigues, DG; Valduga, CJ | 1 |
| Choi, K; Chung, H; Jeong, SY; Kim, IS; Kim, JH; Kim, K; Kim, S; Kim, YS; Kwon, IC; Park, JH; Park, RW | 1 |
| Kim, IS; Kim, JH; Kim, K; Kim, YS; Kwon, IC; Lee, DS; Park, RW; Shim, WS | 1 |
| Banerjee, T; DuHadaway, J; Hou, DY; Johnson, M; Mellor, AL; Muller, AJ; Munn, DH; Prendergast, GC; Sharma, MD | 1 |
| Akhmanova, A; Borisy, GG; Chaga, OY; Komarova, YA; Schober, JM | 1 |
| Asensi, M; Benlloch, M; Brown, BD; Carretero, J; Estrela, JM; Mena, S; Obrador, E; Ortega, A; Petschen, I | 1 |
| McNeely, SC; States, JC; Taylor, BF | 1 |
| Bissery, MC; Combeau, C; Duclos, O; Lavelle, F; Ojima, I; Riou, JF; Vrignaud, P; Zucco, M | 1 |
| Cajone, F; Debiasi, S; Lakshmi, MS; Parker, C; Sherbet, GV | 1 |
| Rozhin, J; Sameni, M; Sloane, BF; Ziegler, G | 1 |
| Bissery, MC; Lavelle, F; Vrignaud, P | 1 |
| Chakravorty, K; Chelvi, TP; De, TK; Kaur, J; Maitra, A; Ralhan, R; Sharma, D | 1 |
| Chelvi, TP; Kaur, J; Ralhan, R; Sharma, D | 1 |
| Beitner, R; Glass-Marmor, L | 1 |
| Arakawa, H; Harada, N; Hashiyama, T; Nakanishi, N; Oda, K; Ozaki, K; Tsujihara, K; Yamaguchi, T | 1 |
| Chai, KB; Choi, SU; Chung, HT; Kim, D; Lee, CO; Lee, KS; Pae, HO; Roh, EJ; Song, CE | 1 |
| Foroncewicz, B; Golab, J; Jakobisiak, M; Mucha, K; Zagozdzon, R | 1 |
| Albeck, M; Catane, R; Kalechman, Y; Longo, DL; Shani, A; Sredni, B | 1 |
| Edatsugi, H; Matsuba, Y; Matsunaga, A; Mita, I; Nakanishi, O | 1 |
| Ballestrem, C; Hinz, B; Imhof, BA; Wehrle-Haller, B | 1 |
| Chiba, J; Iimura, S; Iwahana, M; Jimbo, T; Ohsuki, S; Soga, T; Terasawa, H; Uoto, K; Yoshino, T | 1 |
| Ali, SM; Boge, TC; Georg, GI; Himes, RH; Liu, Y; Marquez, RT; Victory, S; Zygmunt, J | 1 |
| Aoki, J; Kimura, Y; Kohno, M; Nakanishi, O; Ooka, H; Tsuruo, T | 1 |
| Han, R; Lei, X; Liu, H | 1 |
| Bombardelli, E; Borsotti, P; Giavazzi, R; Micheletti, G; Morazzoni, P; Nicoletti, MI; Poli, M; Rieppi, M; Riva, A; Roccabianca, P; Rossi, C; Scanziani, E; Taraboletti, G; Turatto, M | 1 |
| Amiji, MM; Lai, PK; Rao, M; Shenoy, DB | 1 |
| Bissery, MC; Guénard, D; Guéritte-Voegelein, F; Lavelle, F | 1 |
| Chen, WM; Wu, B; Zhang, PL; Zheng, QT | 1 |
2 review(s) available for paclitaxel and B16 Melanoma
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: characterization, preclinical pharmacology, and preliminary clinical data.
Topics: Animals; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Polyglutamic Acid; Taxoids | 2003 |
1 trial(s) available for paclitaxel and B16 Melanoma
129 other study(ies) available for paclitaxel and B16 Melanoma
| Article | Year |
|---|---|
Synthesis of biologically active taxol analogues with modified phenylisoserine side chains.
Topics: Animals; Antineoplastic Agents; Cattle; Drug Screening Assays, Antitumor; In Vitro Techniques; Melanoma, Experimental; Microtubules; Molecular Conformation; Paclitaxel; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Novel cytotoxic 3'-(tert-butyl) 3'-dephenyl analogs of paclitaxel and docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Humans; Melanoma, Experimental; Microtubules; Molecular Structure; Paclitaxel; Solubility; Taxoids; Tumor Cells, Cultured | 1995 |
The effect of the aromatic rings of taxol on biological activity and solution conformation: synthesis and evaluation of saturated taxol and taxotere analogues.
Topics: Antineoplastic Agents; Cell Survival; Chloroform; Dimethyl Sulfoxide; Docetaxel; Melanoma, Experimental; Microtubules; Molecular Conformation; Molecular Structure; Paclitaxel; Solutions; Structure-Activity Relationship; Taxoids | 1994 |
Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Melanoma, Experimental; Mice; Mice, Nude; Molecular Structure; Ovarian Neoplasms; Paclitaxel; Structure-Activity Relationship; Taxoids; Tumor Cells, Cultured | 1996 |
Butitaxel analogues: synthesis and structure-activity relationships.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Melanoma, Experimental; Mice; Microtubules; Paclitaxel; Solubility; Structure-Activity Relationship; Taxoids | 1997 |
12,13-isotaxanes: synthesis of new potent analogs and X-ray crystallographic confirmation of structure.
Topics: Alkaloids; Animals; Antineoplastic Agents; Bridged-Ring Compounds; Crystallography, X-Ray; Female; Humans; Melanoma, Experimental; Mice; Mice, Inbred Strains; Molecular Conformation; Molecular Structure; Ovarian Neoplasms; Paclitaxel; Taxoids; Tumor Cells, Cultured | 1997 |
New highly active taxoids from 9beta-dihydrobaccatin-9,10-acetals. Part 3.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Melanoma, Experimental; Mice; Molecular Conformation; Neoplasm Transplantation; Paclitaxel; Solubility; Tumor Cells, Cultured | 2003 |
Evaluation of apoptotic effect of cyclic imide derivatives on murine B16F10 melanoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Inhibitory Concentration 50; Isoquinolines; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Naphthalimides; Spectrophotometry, Infrared | 2011 |
Bioactive Maleic Anhydrides and Related Diacids from the Aquatic Hyphomycete Tricladium castaneicola.
Topics: Drug Screening Assays, Antitumor; Japan; Maleic Anhydrides; Melanoma, Experimental; Mitosporic Fungi; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phytophthora; Structure-Activity Relationship; Succinates | 2015 |
Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Humans; Liposomes; Melanoma, Experimental; Mice; Paclitaxel; Polyethylene Glycols | 2023 |
Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Delivery Systems; Fatty Acids, Monounsaturated; Glucuronidase; Heparin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Particle Size; Peptides; Protamines; Quaternary Ammonium Compounds; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |
Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death.
Topics: Acids; Animals; B7-H1 Antigen; Cell Line, Tumor; Cell Proliferation; CRISPR-Cas Systems; Cyclin-Dependent Kinase 5; Humans; Immunogenic Cell Death; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; T-Lymphocytes; Transfection; Tumor Microenvironment | 2020 |
An albumin-bound drug conjugate of paclitaxel and indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy.
Topics: Albumins; Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Compounding; Drug Synergism; Female; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; T-Lymphocytes, Regulatory; Treatment Outcome; Tryptophan; Xenograft Model Antitumor Assays | 2020 |
Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy.
Topics: Albumins; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Membrane; Female; Humans; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Tissue Distribution; Xenograft Model Antitumor Assays | 2020 |
Cytotoxic and biomechanical effects of clinical dosing schemes of paclitaxel on neurons and cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Female; Ganglia, Spinal; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neurons; Paclitaxel | 2020 |
Dendrimer-based micelles with highly potent targeting to sites of active bone turnover for the treatment of bone metastasis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid; Bone Neoplasms; Cell Line, Tumor; Cholesterol; Dendrimers; Drug Carriers; Drug Compounding; Female; Injections, Intravenous; Male; Melanoma, Experimental; Mice, Inbred C57BL; Micelles; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats, Wistar; Single Photon Emission Computed Tomography Computed Tomography; Tissue Distribution | 2020 |
LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Contrast Media; Drug Delivery Systems; Lipoproteins, LDL; Liver; Magnetic Resonance Imaging; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Muscles; Nanoparticles; Neoplasms; Paclitaxel; Particle Size; Precision Medicine | 2021 |
Precise ratiometric loading of PTX and DOX based on redox-sensitive mixed micelles for cancer therapy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Survival; Doxorubicin; Drug Carriers; Drug Compounding; Drug Therapy, Combination; Humans; Injections, Intravenous; Male; Melanoma, Experimental; Mice; Micelles; Oxidation-Reduction; Paclitaxel; Polyethylene Glycols; Skin Neoplasms | 2017 |
Paclitaxel nanoparticle awakens immune system to fight against cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cells, Cultured; Click Chemistry; Drug Delivery Systems; Humans; Immune System; Macrophages; Melanoma, Experimental; Mice; Molecular Structure; Nanoparticles; Neoplasms; Paclitaxel; Phagocytosis | 2017 |
Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
Topics: Animals; Antineoplastic Agents; Drug Therapy, Combination; Imidazoles; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Interleukin-2; Isoindoles; Kynurenine; Male; Melanoma, Experimental; Mice, Inbred C57BL; Paclitaxel; T-Lymphocytes; Tryptophan; Tumor Burden | 2017 |
Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Antineoplastic Agents; Capillary Permeability; Cell Line, Tumor; Drug Synergism; Female; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Nitric Oxide; Nitroso Compounds; Paclitaxel; Pancreatic Neoplasms; Protein Multimerization; Serum Albumin, Human | 2017 |
Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence.
Topics: Animals; Antibodies; Cell Line, Tumor; Cytokines; Female; Ganciclovir; Immunologic Surveillance; Killer Cells, Natural; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Recurrence, Local; Oncolytic Virotherapy; Paclitaxel; Reoviridae; Skin Neoplasms; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2017 |
Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti-tumor effects.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Synergism; Female; Immunotherapy; Interleukin-2; Melanoma, Experimental; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Skin Neoplasms | 2018 |
Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents, Phytogenic; Disulfides; Drug Delivery Systems; Female; Hyaluronic Acid; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Nanoparticles; Oxidation-Reduction; Paclitaxel; Tumor Microenvironment | 2018 |
Supermolecular drug challenge to overcome drug resistance in cancer cells.
Topics: Allosteric Regulation; Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Dextrans; Drug Carriers; Drug Compounding; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Melanoma, Experimental; Methylmethacrylates; Mice; Models, Biological; Molecular Structure; Paclitaxel; Structure-Activity Relationship; Tumor Microenvironment | 2018 |
Liposils: An effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica.
Topics: Amines; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Cholesterol; Drug Liberation; Drug Stability; Erythrocytes; Hemolysis; Humans; Liposomes; Male; Melanoma, Experimental; Mice; Paclitaxel; Phosphatidylcholines; Rats, Sprague-Dawley; Silicon Dioxide | 2018 |
A robust control system for targeting melanoma by a supermolecular DDMC/paclitaxel complex.
Topics: Allosteric Site; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; DEAE-Dextran; Female; Humans; Kinetics; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Particle Size; Signal Transduction; Tumor Microenvironment; Zalcitabine | 2018 |
Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies.
Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Endocytosis; Female; Human Umbilical Vein Endothelial Cells; Humans; Injections; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Melanoma, Experimental; Mice; Mice, Nude; Micelles; Nebulizers and Vaporizers; Paclitaxel; Particle Size; Peptides; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Tissue Distribution | 2018 |
Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing.
Topics: Animals; Biomimetics; Cell Line, Tumor; Cell Membrane; Drug Delivery Systems; Humans; Leukocytes; Liposomes; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |
Targeting myeloid regulators by paclitaxel-loaded enzymatically degradable nanocups.
Topics: Animals; Drug Carriers; Gold; Melanoma, Experimental; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Nanotubes, Carbon; Paclitaxel; Reactive Nitrogen Species; Reactive Oxygen Species; Tumor Microenvironment | 2018 |
PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment.
Topics: Animals; Antineoplastic Agents, Phytogenic; B7-H1 Antigen; Calreticulin; Cell Line, Tumor; Melanoma, Experimental; Mice, Inbred C57BL; Micelles; Paclitaxel; Receptor, IGF Type 2; Ribosomal Protein S6 Kinases; RNA, Small Interfering; T-Lymphocytes | 2019 |
Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disulfides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Female; Melanoma, Experimental; Mice; Micelles; Oxidation-Reduction; Paclitaxel; Prodrugs; Propionates; Tumor Burden; Vitamin E | 2019 |
Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Cell Line, Tumor; Female; Galactosylceramides; Immune Tolerance; Lung Neoplasms; Melanoma, Experimental; Mice; Paclitaxel; Skin Neoplasms; T-Lymphocytes, Cytotoxic | 2019 |
A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Calreticulin; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cytokines; Dacarbazine; Disease Models, Animal; Female; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Nanoparticles; Paclitaxel; Peptides; Survival Rate; Tissue Distribution | 2019 |
Biocompatibility and effectiveness of paclitaxel-encapsulated micelle using phosphoester compounds as a carrier for cancer treatment.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Screening Assays, Antitumor; Humans; Male; Melanoma, Experimental; Mice; Micelles; Molecular Structure; Organophosphates; Paclitaxel; Particle Size; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Surface Properties | 2019 |
α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Breast Neoplasms; Cell Proliferation; Dendrimers; Drug Carriers; Drug Delivery Systems; Female; Humans; In Vitro Techniques; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Nylons; Paclitaxel; Polyamines; Polyethylene Glycols; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12.
Topics: Adenoviridae; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Genetic Therapy; Genetic Vectors; Humans; Immunotherapy; Interferon-gamma; Interleukin-12; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Recombinant Proteins; Transduction, Genetic | 2013 |
Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chitosan; Drug Carriers; Female; HeLa Cells; Humans; Lipids; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Phosphatidylethanolamines; Rats; Rats, Wistar; Transport Vesicles | 2013 |
Overexpression of Heat Shock Transcription Factor 1 enhances the resistance of melanoma cells to doxorubicin and paclitaxel.
Topics: Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression; Gene Silencing; Heat Shock Transcription Factors; Humans; Inhibitory Concentration 50; Melanoma; Melanoma, Experimental; Mice; Mutation; Paclitaxel; Transcription Factors | 2013 |
Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cancer Vaccines; Carcinoma, Lewis Lung; Cells, Cultured; Dendritic Cells; Flow Cytometry; Immunotherapy; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Cells; Paclitaxel; Receptors, Chemokine; rho GTP-Binding Proteins; T-Lymphocytes, Regulatory; Toll-Like Receptor 4; Tumor Microenvironment | 2014 |
Development of polymeric nanopaclitaxel and comparison with free paclitaxel for effects on cell proliferation of MCF-7 and B16F0 carcinoma cells.
Topics: Acrylamides; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Delayed-Action Preparations; Drug Carriers; Humans; MCF-7 Cells; Melanoma, Experimental; Nanoparticles; Paclitaxel; Particle Size; Polymers | 2014 |
Self-assembled chitosan-ceramide nanoparticle for enhanced oral delivery of paclitaxel.
Topics: Administration, Oral; Animals; Cell Line, Tumor; Ceramides; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Emulsions; Humans; MCF-7 Cells; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size | 2014 |
Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Combined Modality Therapy; Dacarbazine; Drug Synergism; Female; Immunotherapy; Interleukin-2; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Paclitaxel; Recombinant Fusion Proteins; Tissue Distribution; Tumor Necrosis Factor-alpha | 2014 |
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chickens; Clarithromycin; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Drug Compounding; Gastrointestinal Tract; Hypromellose Derivatives; Ileum; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Skin Neoplasms; Surface Properties; Tumor Burden | 2014 |
Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Survival; Chemistry, Pharmaceutical; Drug Stability; Female; G2 Phase Cell Cycle Checkpoints; Half-Life; Humans; Injections, Intravenous; Lipids; Liposomes; Male; MCF-7 Cells; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Solubility; Technology, Pharmaceutical; Tissue Distribution | 2015 |
Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Disulfides; Drug Delivery Systems; Hemolysis; Humans; Hydrogen-Ion Concentration; Lysine; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Oxidation-Reduction; Paclitaxel; Pentetic Acid; Polyethylene Glycols; Polymers | 2014 |
Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.
Topics: Adenoviridae; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemokine CCL21; Cytokines; Cytotoxicity, Immunologic; Disease Models, Animal; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Melanoma, Experimental; Mice; Neoplasms; Neovascularization, Pathologic; Paclitaxel; T-Cell Antigen Receptor Specificity; T-Lymphocyte Subsets; Tumor Burden | 2014 |
[Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].
Topics: Animals; Annexin A5; Apoptosis; Cell Line, Tumor; Cell-Penetrating Peptides; Fluorescein-5-isothiocyanate; Liposomes; Melanoma, Experimental; Mice; Microscopy, Confocal; Paclitaxel; Particle Size; Polyethylene Glycols | 2014 |
Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment.
Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Synergism; Lactic Acid; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microspheres; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Random Allocation; Treatment Outcome; Xenograft Model Antitumor Assays | 2014 |
Codelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumor.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Liposomes; Melanoma, Experimental; Mice; Paclitaxel | 2014 |
Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Animals; Antineoplastic Agents, Phytogenic; Biomimetic Materials; Cell Line, Tumor; Cell Survival; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanospheres; Paclitaxel; Phosphatidylethanolamines; Pulmonary Surfactants; Skin Neoplasms; Vasodilation | 2014 |
Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell-Penetrating Peptides; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Glutathione; Lipids; Liposomes; Male; Melanoma, Experimental; Mice, Inbred C57BL; Nanotechnology; Oxidation-Reduction; Paclitaxel; Polyethylene Glycols; tat Gene Products, Human Immunodeficiency Virus; Technology, Pharmaceutical | 2015 |
Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature.
Topics: Animals; Antineoplastic Agents, Phytogenic; Capillary Permeability; Cell Line, Tumor; Light; Liposomes; Melanoma, Experimental; Mice, Inbred BALB C; Mice, Inbred C57BL; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Protoporphyrins; Skin Neoplasms; Tumor Burden | 2015 |
Medicinal facilities to B16F10 melanoma cells for distant metastasis control with a supramolecular complex by DEAE-dextran-MMA copolymer/paclitaxel.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dextrans; Female; Liver Neoplasms; Lung Neoplasms; Melanoma, Experimental; Methylmethacrylates; Mice, Inbred C57BL; Paclitaxel; Tumor Burden | 2015 |
Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; MCF-7 Cells; Melanoma, Experimental; Mice; Micelles; Microscopy, Electron, Transmission; Models, Chemical; Molecular Structure; Paclitaxel; Poloxalene; Polymers; Treatment Outcome | 2015 |
Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Antineoplastic Agents; Becaplermin; Carboplatin; Cell Line, Tumor; Cell Movement; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Female; Humans; Lung Neoplasms; Lysophospholipids; Melanoma, Experimental; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Paclitaxel; Placenta Growth Factor; Pregnancy Proteins; Proto-Oncogene Proteins c-sis; Receptors, CXCR4; Receptors, Interleukin-8B; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Stromal Cells; Time Factors; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |
Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Female; Humans; Male; Melanoma, Experimental; Mice; Mice, Nude; Models, Animal; Molecular Targeted Therapy; Paclitaxel; Pancreatic Neoplasms; Rats; Receptor, EphA2; Xenograft Model Antitumor Assays | 2015 |
A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Coculture Techniques; Drug Liberation; Female; Humans; Hydrogen-Ion Concentration; Integrin alphaVbeta3; Liposomes; Melanoma, Experimental; Mice, Inbred C57BL; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols | 2015 |
Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Bone Marrow Cells; Combined Modality Therapy; Cytokines; Dendritic Cells; Female; Immunotherapy; Interleukin-10; Interleukin-12; Lactic Acid; Lymph Nodes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Oligodeoxyribonucleotides; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; Toll-Like Receptor 9 | 2015 |
Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Erythrocytes; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Inulin; Male; Melanoma, Experimental; Mice, Inbred C57BL; Micelles; Paclitaxel; Tumor Burden | 2016 |
Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy.
Topics: Animals; Bronchoalveolar Lavage; Cell Line, Tumor; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Half-Life; Lung Neoplasms; Melanoma, Experimental; Mice; Molecular Weight; Paclitaxel; Polyethylene Glycols | 2016 |
Identification of anti-cancer chemical compounds using Xenopus embryos.
Topics: Animals; Antineoplastic Agents; Benzodioxoles; Benzofurans; Carbolines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Evaluation, Preclinical; Embryo Loss; Embryo, Nonmammalian; Female; Gastrulation; Glioma; Indole Alkaloids; Melanoma, Experimental; Mice; Microtubules; Neoplasm Invasiveness; Paclitaxel; Podophyllotoxin; Rats; Receptors, CXCR4; Xenograft Model Antitumor Assays; Xenopus | 2016 |
Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Proliferation; Cholesterol, LDL; Drug Synergism; Female; Immunoenzyme Techniques; Injections, Intraperitoneal; Lipids; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Receptors, LDL; Simvastatin; Tumor Cells, Cultured | 2016 |
Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Compounding; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Hydrogen-Ion Concentration; Imidazoles; Liposomes; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Phosphatidylethanolamines; Proto-Oncogene Proteins c-bcl-2; Pyrones; RNA, Small Interfering; Skin Neoplasms; Tumor Burden | 2016 |
Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.
Topics: Albumins; Animals; Female; Fibrin; Fibrinolysis; Fibrinolytic Agents; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanomedicine; Paclitaxel; Tissue Plasminogen Activator; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Capillary Permeability; Cations; Cisplatin; Cricetinae; Liposomes; Male; Melanoma, Experimental; Mesocricetus; Neovascularization, Pathologic; Paclitaxel | 2008 |
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Proliferation; Chemokine CXCL12; Deoxycytidine; Drug Therapy, Combination; Endothelial Cells; Female; Gemcitabine; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Paclitaxel; Stem Cells; Tumor Burden; Vascular Endothelial Growth Factor A | 2008 |
Analysis of cell cycle phases and proliferative capacity in mice bearing melanoma maintained on different dietary proteins.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cattle; Cell Cycle; Cell Proliferation; Collagen; Diet; Dietary Proteins; Melanoma, Experimental; Mice; Milk Proteins; Nucleolus Organizer Region; Paclitaxel; Whey Proteins | 2009 |
Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Diglycerides; Drug Carriers; Hydrogen-Ion Concentration; Melanoma, Experimental; Mice; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Particle Size | 2009 |
A novel triterpenoid isolated from the root bark of Ailanthus excelsa Roxb (Tree of Heaven), AECHL-1 as a potential anti-cancer agent.
Topics: Ailanthus; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Paclitaxel; Plants, Medicinal; Prostatic Neoplasms; Transplantation, Heterologous; Triterpenes; Tumor Suppressor Proteins | 2009 |
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Proteins; Transplantation, Heterologous; Treatment Outcome | 2010 |
Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Stability; Freeze Drying; Lipids; Liposomes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanotechnology; Paclitaxel; Particle Size; Xenograft Model Antitumor Assays | 2010 |
Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Topics: Animals; Antineoplastic Agents; Cations; Cell Line, Tumor; Doxorubicin; Drug Carriers; Female; Fibroblast Growth Factor 2; Flow Cytometry; In Situ Nick-End Labeling; Injections, Intravenous; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Atomic Force; Neoplasm Transplantation; Paclitaxel; Particle Size; Prostatic Neoplasms; Protein Binding; Receptors, Fibroblast Growth Factor; Surface Properties | 2010 |
Actin-sequestering protein, thymosin beta-4, induces paclitaxel resistance through ROS/HIF-1alpha stabilization in HeLa human cervical tumor cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Nucleus; Cell Survival; Cytosol; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Flow Cytometry; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; NF-kappa B; Paclitaxel; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Thymosin | 2010 |
Antitumor activity of theophylline in combination with Paclitaxel: a preclinical study on melanoma experimental lung metastasis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Drug Evaluation, Preclinical; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Theophylline; Vasodilator Agents | 2010 |
Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Delivery Systems; Immunotherapy; Lipopolysaccharides; Macrophage Activation; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanocapsules; Paclitaxel | 2010 |
Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Cations; Cell Line, Tumor; Drug Delivery Systems; Drug Stability; Female; Fibroblast Growth Factor 2; Injections, Intravenous; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Particle Size; Tissue Distribution | 2011 |
Combination therapy using imatinib and vatalanib improves the therapeutic efficiency of paclitaxel towards a mouse melanoma tumor.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Becaplermin; Benzamides; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Imatinib Mesylate; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Phthalazines; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins c-sis; Pyridines; Pyrimidines; RNA, Small Interfering; Signal Transduction | 2011 |
[Study on the anti-tumor effect of paclitaxel mixed micelle by using in vivo optical imaging technique].
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Luminescent Measurements; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Micelles; Neoplasm Transplantation; Paclitaxel; Particle Size; Tumor Burden | 2010 |
pH triggered injectable amphiphilic hydrogel containing doxorubicin and paclitaxel.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Hydrogels; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Polyethylene Glycols; Rheology; Skin Neoplasms; Survival Rate; Time Factors | 2011 |
The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Lung Neoplasms; Melanoma, Experimental; Mice; Micelles; Microscopy, Electron, Scanning; Paclitaxel; Poloxamer; Skin Neoplasms; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2011 |
Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Capillary Permeability; Cell Line, Tumor; Drug Synergism; Female; Fibronectins; Humans; Interleukin-2; Melanoma, Experimental; Mice; Paclitaxel; Protein Isoforms; Xenograft Model Antitumor Assays | 2012 |
Poly(ethylene carbonate) nanoparticles as carrier system for chemotherapy showing prolonged in vivo circulation and anti-tumor efficacy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbon Radioisotopes; Drug Carriers; Drug Compounding; Drug Stability; Humans; Lactic Acid; Melanoma, Experimental; Mice; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Particle Size; Polyethylenes; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Tumor Burden | 2012 |
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Female; HCT116 Cells; Humans; Hyaluronic Acid; Lipids; Melanoma, Experimental; Mice; Nanostructures; Paclitaxel; Random Allocation | 2013 |
Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxel.
Topics: Animals; Antigens, Bacterial; Antineoplastic Agents, Phytogenic; Bacterial Toxins; Cell Line, Tumor; Cell Survival; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Skin Neoplasms; Tumor Burden; Urokinase-Type Plasminogen Activator | 2013 |
Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Binding Sites; Cell Line, Tumor; Cholesterol; Drug Stability; Female; Humans; Ligands; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Peptides; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Random Allocation; Receptors, Fibroblast Growth Factor; Tissue Distribution | 2012 |
Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cholesterol, LDL; Drug Delivery Systems; Etoposide; Fat Emulsions, Intravenous; Female; Flow Cytometry; Injections, Intraperitoneal; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Paclitaxel | 2012 |
Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Hepatocellular; Drug Carriers; Drug Delivery Systems; Drug Synergism; Female; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Hyaluronic Acid; Injections, Intravenous; Liver Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Tissue Distribution; Xenograft Model Antitumor Assays | 2013 |
Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier.
Topics: Animals; Apoptosis; Cells, Cultured; Drug Carriers; Female; Flow Cytometry; Hemolysis; Hep G2 Cells; Humans; Hyaluronic Acid; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Rabbits; Tretinoin | 2013 |
Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy.
Topics: Animals; Antineoplastic Agents; Cell Survival; Doxorubicin; Drug Carriers; Fluorescein-5-isothiocyanate; Lung Neoplasms; Melanoma, Experimental; Mice; Nanomedicine; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polyglutamic Acid | 2013 |
Cephalosporin prodrugs of paclitaxel for immunologically specific activation by L-49-sFv-beta-lactamase fusion protein.
Topics: Antineoplastic Agents, Phytogenic; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Cyclization; Enzyme Inhibitors; Half-Life; Humans; Immunoglobulin G; In Vitro Techniques; Indicators and Reagents; Melanoma, Experimental; Paclitaxel; Prodrugs; Recombinant Fusion Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Capsules; Cations; Cell Division; Endothelium, Vascular; Humans; Liposomes; Melanoma, Experimental; Mice; Mice, SCID; Mitotic Index; Neoplasm Invasiveness; Neovascularization, Pathologic; Paclitaxel; Skin Neoplasms; Tumor Cells, Cultured | 2003 |
Anti-invasion and anti-angiogenesis effect of taxol and camptothecin on melanoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Adhesion; Cell Movement; Chick Embryo; Collagenases; Humans; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Paclitaxel; Tumor Cells, Cultured | 2003 |
Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Cell Line, Tumor; Cell Movement; Cell Survival; Enzyme Inhibitors; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Paclitaxel; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases | 2003 |
Tumor growth retardation, cure, and induction of antitumor immunity in B16 melanoma-bearing mice by low electric field-enhanced chemotherapy.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Cell Division; Cisplatin; Combined Modality Therapy; Electric Stimulation Therapy; Macrophages; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Spleen; T-Lymphocytes; Time Factors | 2003 |
Taxol inhibits melanoma metastases through apoptosis induction, angiogenesis inhibition, and restoration of E-cadherin and nm23 expression.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cadherins; Coloring Agents; Eosine Yellowish-(YS); Fluorescent Dyes; Hematoxylin; Immunohistochemistry; In Situ Hybridization; In Situ Nick-End Labeling; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Electron; Neovascularization, Pathologic; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Paclitaxel; Protein Biosynthesis; RNA, Messenger; Vascular Endothelial Growth Factor A | 2003 |
Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.
Topics: Animals; Antineoplastic Agents; DNA-Binding Proteins; Ethylenes; Humans; Interleukin-10; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasms; Oligonucleotides, Antisense; Paclitaxel; Phosphorylation; STAT3 Transcription Factor; Trans-Activators | 2004 |
Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.
Topics: Animals; Cricetinae; Drug Carriers; Erythrocytes; In Situ Nick-End Labeling; Liposomes; Male; Melanoma, Experimental; Mesocricetus; Microcirculation; Neovascularization, Pathologic; Paclitaxel; Regional Blood Flow | 2004 |
Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP).
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Humans; Interleukin-6; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Paclitaxel; Panax; Phytotherapy; Plant Extracts; Plant Roots; Polysaccharides; Specific Pathogen-Free Organisms; Spleen | 2004 |
In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Injections, Intravenous; Melanoma, Experimental; Mice; Nanostructures; Neoplasm Transplantation; Paclitaxel | 2005 |
Stable paclitaxel formulations in oily contrast medium.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Contrast Media; Doxorubicin; Drug Stability; Emulsions; Female; Iodized Oil; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms; Oils; Paclitaxel; Solubility; Solvents | 2005 |
Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cholesterol; Drug Carriers; Drug Stability; Emulsions; Humans; Lethal Dose 50; Melanoma, Experimental; Mice; Nanostructures; Neoplasm Transplantation; Paclitaxel; Receptors, LDL; Structure-Activity Relationship | 2005 |
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Glycerol; Humans; Hydrophobic and Hydrophilic Interactions; Injections, Intravenous; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanostructures; Paclitaxel; Technology, Pharmaceutical; Time Factors; Treatment Outcome | 2006 |
pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Delayed-Action Preparations; Drug Carriers; Hydrogels; Hydrogen-Ion Concentration; In Situ Nick-End Labeling; Injections, Subcutaneous; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Polymers; Skin Neoplasms; Temperature | 2007 |
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dendritic Cells; Drug Synergism; Female; HeLa Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Paclitaxel; Stereoisomerism; Tryptophan | 2007 |
Microtubule-targeting-dependent reorganization of filopodia.
Topics: Animals; Antibodies, Monoclonal; Cell Adhesion; Cells, Cultured; Fluorescent Antibody Technique, Direct; Fluorescent Dyes; Focal Adhesions; Immunohistochemistry; Kinetics; Luminescent Proteins; Melanoma, Experimental; Mice; Microscopy, Fluorescence; Microtubules; Nocodazole; Paclitaxel; Phalloidine; Pseudopodia; RNA Interference; Transfection; Tubulin; Tubulin Modulators | 2007 |
Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
Topics: Animals; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Glutamine; Glutathione; Melanoma, Experimental; Mice; Neoplasm Metastasis; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Thionucleotides; Treatment Outcome; Tumor Necrosis Factor-alpha; X-Rays | 2007 |
Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Arsenites; Blotting, Western; CDC2 Protein Kinase; Fluorescent Antibody Technique; Humans; Melanoma, Experimental; Mitosis; Nocodazole; Paclitaxel; Protein Serine-Threonine Kinases; Purines; RNA, Small Interfering; Roscovitine; Sodium Compounds | 2008 |
Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3' and/or C-2 of taxotere (docetaxel).
Topics: Animals; Antineoplastic Agents, Phytogenic; Docetaxel; Doxorubicin; Drug Resistance; Leukemia P388; Melanoma, Experimental; Mice; Microtubules; Molecular Structure; Paclitaxel; Structure-Activity Relationship; Taxoids | 1994 |
Metastasis-associated mts1 gene expression is down-regulated by heat shock in variant cell lines of the B16 murine melanoma.
Topics: alpha-MSH; Animals; Cell Division; Cell Line; Clone Cells; Gene Expression Regulation, Neoplastic; Genetic Variation; Heat-Shock Proteins; Hot Temperature; Melanoma, Experimental; Methionine; Mice; Neoplasm Metastasis; Paclitaxel; Sulfur Radioisotopes; Tretinoin | 1994 |
Pericellular pH affects distribution and secretion of cathepsin B in malignant cells.
Topics: Animals; Cathepsin B; Cell Membrane; Colorectal Neoplasms; Fibrocystic Breast Disease; Humans; Hydrogen-Ion Concentration; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microtubules; Nocodazole; Paclitaxel; Tumor Cells, Cultured | 1994 |
Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Docetaxel; Female; Humans; Leukemia P388; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Paclitaxel; Taxoids | 1995 |
Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Compounding; Drug Screening Assays, Antitumor; Emulsions; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Particle Size; Povidone | 1996 |
Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cholesterol; Combined Modality Therapy; Drug Carriers; Ethanol; Hot Temperature; Hyperthermia, Induced; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Phosphatidylcholines; Random Allocation; Survival Rate | 1998 |
Taxol (paclitaxel) induces a detachment of phosphofructokinase from cytoskeleton of melanoma cells and decreases the levels of glucose 1,6-bisphosphate, fructose 1,6-bisphosphate and ATP.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Cytoskeleton; Dose-Response Relationship, Drug; Fructosediphosphates; Glucose-6-Phosphate; Glycolysis; Melanoma, Experimental; Mice; Paclitaxel; Phosphofructokinase-1 | 1999 |
Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Docetaxel; Drug Screening Assays, Antitumor; Humans; Melanoma, Experimental; Mice; Neoplasm Transplantation; Paclitaxel; Prodrugs; Solubility; Structure-Activity Relationship; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured; Water | 1999 |
Synthesis and biology of 3'-N-acyl-N-debenzoylpaclitaxel analogues.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; HL-60 Cells; Humans; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Paclitaxel; Spectrometry, Mass, Fast Atom Bombardment | 1999 |
Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Screening Assays, Antitumor; Drug Synergism; Immunologic Factors; Immunotherapy; Interleukin-12; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Paclitaxel; Recombinant Proteins | 1999 |
Synergistic anti-tumoral effect of paclitaxel (Taxol)+AS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow; Cell Cycle; Drug Synergism; Enzyme Activation; Ethylenes; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Neoplasm Transplantation; Paclitaxel; Proto-Oncogene Proteins c-raf; ras Proteins; Signal Transduction; Spleen | 2000 |
A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Benzimidazoles; Cell Survival; Cisplatin; Colonic Neoplasms; DNA; Female; Fluorescent Dyes; Humans; Leukemia L1210; Leukemia P388; Macromolecular Substances; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Paclitaxel; Pyrroles; Radiation-Sensitizing Agents | 2000 |
Actin-dependent lamellipodia formation and microtubule-dependent tail retraction control-directed cell migration.
Topics: Actins; Animals; Cell Line; Cell Movement; Cytoplasm; Green Fluorescent Proteins; Luminescent Proteins; Melanocytes; Melanoma, Experimental; Mice; Microtubules; Nocodazole; Paclitaxel; Proto-Oncogene Proteins c-kit; rac GTP-Binding Proteins; Recombinant Fusion Proteins; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured | 2000 |
Orally active docetaxel analogue: synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Cell Division; Combinatorial Chemistry Techniques; Docetaxel; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Morpholines; Paclitaxel; Solubility; Structure-Activity Relationship; Survival Rate; Taxoids; Tumor Cells, Cultured | 2001 |
A systematic SAR study of C10 modified paclitaxel analogues using a combinatorial approach.
Topics: Animals; Breast Neoplasms; Chromatography, Thin Layer; Combinatorial Chemistry Techniques; Drug Resistance, Neoplasm; Fatty Acids; Humans; Hydrocarbons, Alicyclic; Hydrocarbons, Aromatic; Mass Spectrometry; Melanoma, Experimental; Mice; Nuclear Magnetic Resonance, Biomolecular; Paclitaxel; Solutions; Spectrometry, Mass, Fast Atom Bombardment; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Cyclosporine; Cyclosporins; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Quinolines; Rats; Rats, Sprague-Dawley | 2002 |
[Anti-invasion activity of several plant-originated anticancer drugs with different mechanism of action].
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Cell Movement; Fibrosarcoma; Harringtonines; Homoharringtonine; Humans; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Paclitaxel; Plant Bark; Plant Roots; Taxus; Tumor Cells, Cultured | 1998 |
Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bridged-Ring Compounds; Cell Division; Cell Line; Cell Movement; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neovascularization, Physiologic; Ovarian Neoplasms; Paclitaxel; Taxoids; Time Factors; Tubulin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Gels; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Poloxamer; Solubility | 2002 |
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Intraductal, Noninfiltrating; Colonic Neoplasms; Docetaxel; Female; Leukemia, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Paclitaxel; Pancreatic Neoplasms; Sarcoma, Experimental; Taxoids | 1991 |
[Studies on the chemical constituents of Taxus yunnanensis].
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Diterpenes; Drugs, Chinese Herbal; Melanoma, Experimental; Molecular Structure; Neoplasm Transplantation; Paclitaxel; Sarcoma 180; Taxoids; Tumor Cells, Cultured | 1991 |